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Different decision deficits impair response
inhibition in progressive supranuclear palsy
and Parkinson’s disease
Jiaxiang Zhang,1,2 Timothy Rittman,3 Cristina Nombela,3 Alessandro Fois,3
Ian Coyle-Gilchrist,3 Roger A. Barker,3 Laura E. Hughes2,3 and James B. Rowe2,3,4
Progressive supranuclear palsy and Parkinson’s disease have distinct underlying neuropathology, but both diseases affect cognitive
function in addition to causing a movement disorder. They impair response inhibition and may lead to impulsivity, which can
occur even in the presence of profound akinesia and rigidity. The current study examined the mechanisms of cognitive impairments
underlying disinhibition, using horizontal saccadic latencies that obviate the impact of limb slowness on executing response
decisions. Nineteen patients with clinically diagnosed progressive supranuclear palsy (Richardson’s syndrome), 24 patients with
clinically diagnosed Parkinson’s disease and 26 healthy control subjects completed a saccadic Go/No-Go task with a head-mounted
infrared saccadometer. Participants were cued on each trial to make a pro-saccade to a horizontal target or withhold their
responses. Both patient groups had impaired behavioural performance, with more commission errors than controls. Mean saccadic
latencies were similar between all three groups. We analysed behavioural responses as a binary decision between Go and No-Go
choices. By using Bayesian parameter estimation, we ﬁtted a hierarchical drift–diffusion model to individual participants’ single
trial data. The model decomposes saccadic latencies into parameters for the decision process: decision boundary, drift rate of
accumulation, decision bias, and non-decision time. In a leave-one-out three-way classiﬁcation analysis, the model parameters
provided better discrimination between patients and controls than raw behavioural measures. Furthermore, the model revealed
disease-speciﬁc deﬁcits in the Go/No-Go decision process. Both patient groups had slower drift rate of accumulation, and shorter
non-decision time than controls. But patients with progressive supranuclear palsy were strongly biased towards a pro-saccade
decision boundary compared to Parkinson’s patients and controls. This indicates a prepotency of responding in combination with a
reduction in further accumulation of evidence, which provides a parsimonious explanation for the apparently paradoxical com-
bination of disinhibition and severe akinesia. The combination of the well-tolerated oculomotor paradigm and the sensitivity of the
model-based analysis provides a valuable approach for interrogating decision-making processes in neurodegenerative disorders.
The mechanistic differences underlying participants’ poor performance were not observable from classical analysis of behavioural
data, but were clearly revealed by modelling. These differences provide a rational basis on which to develop and assess new
therapeutic strategies for cognition and behaviour in these disorders.
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Introduction
Parkinson’s disease and progressive supranuclear palsy
(PSP) are associated with many non-motor symptoms as
well as the motor hallmarks of bradykinesia and rigidity.
Despite very different underlying neuropathology (Hauw
et al., 1994; Litvan et al., 1996b; Braak et al., 2003),
both disorders may lead to executive dysfunction and im-
pulsivity. Impulse control disorders are severe in 10% of
patients with Parkinson’s disease (Weintraub et al., 2010),
but patients are impaired in response inhibition and deci-
sion-making even in the absence of impulse control dis-
orders, and also before they are exposed to any
dopaminergic therapies (Obeso et al., 2011; Nombela
et al., 2014; Ye et al., 2014a). The Richardson’s syndrome
or ‘classical’ phenotype of PSP also causes impulsivity des-
pite severe akinesia and apathy (O’Sullivan et al., 2010;
Burrell et al., 2014). It manifests as delay intolerance,
choice impulsivity, and behavioural decisions that increase
the risk of falls, and it can exacerbate dysphagia and carer
burden (Wedderburn et al., 2008; Burrell et al., 2014).
There are several candidate mechanisms by which PSP
and Parkinson’s disease may lead to impulsivity and poor
response inhibition. For example, loss of subthalamic inhib-
ition would lead to a bias towards action and away from
response inhibition, by disinhibition of thalamocortical pro-
jections (Frank et al., 2007; Averbeck et al., 2014). Cortical
neuropathology, especially in prefrontal and premotor cir-
cuits (Braak et al., 2003; Brenneis et al., 2004; Rae et al.,
2012) may also impair the appropriate accumulation of
evidence for action and inhibition in a given context
(Verbruggen and Logan, 2009), and impair the selection
and execution of actions (Zhang et al., 2012). Finally,
changes in dopaminergic, serotonergic and noradrenergic
innervation of the cortex and striatum can inﬂuence deci-
sion-making and response inhibition (Ye et al., 2014a, b),
while dopaminergic therapies themselves can increase risk-
taking behaviours and impulsivity (Weintraub et al., 2010).
The different features of PSP and Parkinson’s disease
mean that behavioural deﬁcits in response inhibition may
have different origins in these two disorders. In Parkinson’s
disease for example, the impulsive choice arising from
dopaminergic stimulation is distinct from the impulsive
choice arising from therapeutic deep brain stimulation of
the subthalamic nucleus (Frank et al., 2007).
We tested this hypothesis in two clinically diagnosed pa-
tient groups and a healthy control group on a saccadic Go/
No-Go task (Fig. 1A). The reason for the use of saccadic
measures is 2-fold: (i) the precision of the oculomotor
system that enables accurate recording and modelling;
and (ii) the advantage of measuring the time to initiate
movement, not execution time, in patients with
bradykinesia.
The underlying cognitive deﬁcits were revealed by forma-
lizing the Go/No-Go task as an accumulation-to-threshold
decision process, which can be described by a drift-
diffusion model (DDM) (Gomez et al., 2007; Ratcliff
and McKoon, 2008). This model provides a parsimonious
account of complex behavioural phenomena, including re-
sponse latency distributions (Ratcliff and Smith, 2004),
speed accuracy trade-offs (Zhang and Rowe, 2014), and
the effects of uncertainty on decision-making (Mulder
et al., 2012). The DDM also has direct neurophysiological
evidence in support of it, for neurons in the superior col-
liculus (Ratcliff et al., 2003) and cortex (Kim and Shadlen,
1999; Shadlen and Newsome, 2001), while related methods
have been used to examine anatomical correlates from
functional brain imaging data (Rowe et al., 2010; Zhang
et al., 2012). This model-based approach has proven valu-
able and has already revealed the critical role of the sub-
thalamic nuclei for motor inhibition under conditions of
ambiguity or risk (Cavanagh et al., 2011) and the effect
of subthalamotomy on inhibitory behaviour (Obeso et al.,
2014).
Accurate ﬁtting of the model in studies of animals and
healthy participants often requires thousands of trials
(Brunton et al., 2013). This would not be tolerated by pa-
tients with neurodegenerative disorders. We therefore used
a Bayesian parameter estimation approach to ﬁt a hierarch-
ical DDM that encompasses patient heterogeneity in terms
of random sampling of individuals from a group-wise dis-
tribution (Wiecki et al., 2013). By optimizing the model to
ﬁt both the distribution of response latencies and the ac-
curacy of responses, the hierarchical DDM is efﬁcient at
reproducing behavioural data and the properties of genera-
tive decision processes, within a few trials.
The DDM assumes that a single accumulator integrates
the momentary evidence over time. This accumulation pro-
cess terminates when the accumulated evidence reaches an
upper or a lower boundary, corresponding to the Go or
No-Go decisions (Fig. 1B). Impulsive behaviour in the Go/
No-Go task can be decomposed into different changes in
parameters of the DDM, for example a baseline bias to-
wards ‘Go’ decisions (Mulder et al., 2012), or reduced ac-
cumulation rate for ‘No-Go’ decisions (Obeso et al., 2014).
We predicted that both PSP and Parkinson’s disease
impair response inhibition but the hierarchical DDM
would reveal different causes of these deﬁcits in the two
diseases. Knowledge of these mechanisms may not only
increase our ability to detect such deﬁcits, but
would also enable the development of better mechanistic
therapies.
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Materials and methods
Participants
Sixty-nine participants were recruited. Demographic and clin-
ical features of the participants are summarized in Table 1.
Nineteen patients with PSP were recruited from a regional spe-
cialist clinic for PSP and related disorders at the Cambridge
University Hospitals NHS Foundation Trust. Consensus clin-
ical diagnostic criteria (Litvan et al., 1996a) for probable PSP
were used by an experienced neurologist, identifying the
Richardson’s syndrome phenotype. To date, 10 of the clinic-
ally diagnosed patients have died and been recruited to the
Cambridge Brain Bank as part of a separate research pro-
gramme: all 10 had neuropathological conﬁrmation of the
diagnosis.
Twenty-four patients with idiopathic Parkinson’s disease
(Hoehn and Yahr stage I–III) were recruited through the
Cambridge University Parkinson’s Disease Research Clinic.
All Parkinson’s patients met the United Kingdom Parkinson’s
Disease Society Brain Bank Clinical Diagnostic Criteria
(Gibb and Lees, 1988). Patients with Parkinson’s disease did
not have pathological conﬁrmation. Additional inclusion
criteria were: (i) non-demented at last clinical assessment
(Mini-Mental State Examination score, MMSE5 24/30); (ii)
no ongoing clinically signiﬁcant depression (Beck Depression
Inventory score418; Beck et al., 1988).
Twenty-six healthy control participants with no history of
signiﬁcant neurological or psychiatric disorders were recruited
from the volunteer panel of the Medical Research Council
Cognition and Brain Sciences Unit.
Participants underwent cognitive assessment using the
Revised Addenbrooke’s Cognitive Examination (ACE-R) and
Mini-Mental State Examination. Disease severity was assessed
by the PSP Rating Scale (PSPRS) (Golbe and Ohman-
Strickland, 2007) and the Uniﬁed Parkinson Disease Rating
Scale (UPDRS, part III motor subscale) (Fahn, 1986). All test-
ing was performed with participant’s taking their usual medi-
cation. The study was approved by the local research ethics
committee. Written informed consent was obtained from all
participants.
Task and procedure
All participants performed a saccadic Go/No-Go task (Fig. 1A;
Nombela et al., 2014). Each participant sat at a distance of
1.5m from a blank screen wearing a head-mounted saccad-
ometer (Ober consulting) with a binocular infra-red scleral
oculometer for measurement of horizontal movements. The
infrared reﬂectance signals were recorded at 1 kHz and low
pass ﬁltered at 250Hz, with 12 bit resolution. Three low-
power lasers were mounted on the forehead plate and angled
at 10, 0 and + 10 azimuth for stimulus presentation.
Because the device and target display moves with the head, a
head restraint or a bite bar is not required.
Each experiment session consisted of 300 trials. At the be-
ginning of each trial, the participants ﬁxated on two central
spots at 0 (one green, one red). After a random period be-
tween 1500ms and 2500ms, one of the central spots was ex-
tinguished and simultaneously a red target spot was presented
with a 10 or + 10 horizontal displacement. In 50% of the
trials, the green central spot remained and the participants
were required to make a saccade to the lateral target (Go
trials). In the other 50% of trials, the red central spot re-
mained and the participants were required to hold their sac-
cade and maintain ﬁxation (No-Go trials). The lateral target
disappeared 250ms after a saccade was made, or after a max-
imum duration of 1500ms was reached. The order of the
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Figure 1 Saccadic Go/No-Go task and the drift-diffusion
model. (A) Participants fixated on green and red points overlap-
ping at the centre of the screen. One of the two points disappeared
and a saccadic target was presented on the left or right of the
screen at an angle of 10 from the fixation point. Participants were
instructed to make a saccade to the target if the remaining fixation
point was green, or withhold their response if the remaining fixation
point was red. (B) Examples of trajectories of the drift-diffusion
model. Two decision boundaries (0 and a) represent the Go and
No-Go decisions. The drift rate v represents the rate of accumu-
lation. The diffusion process starts at a starting point between the
two boundaries (a*z) until the accumulated evidence reaches one of
the two boundaries. The predicted saccadic latency is the sum of
the duration of the diffusion process and the non-decision time Ter.
Table 1 Demographics and neuropsychological meas-
ures of participants with PSP, Parkinson’s disease and
healthy control subjects
PSP (n = 19) PD (n = 24) Control (n = 26)
Age 68.37  6.54 66.17  10.15 66.58  7.10
Gender 8 M / 11 F 13 M / 11 F 10 M / 16 F
MMSE 26.58  3.73 28.29  1.92 29.46  0.95
ACE-R 79.89  12.23 89.63  8.72 94.62  4.05
PSPRS 38.16  16.89 – –
UPDRS-III – 33.88  15.89 –
Values are mean  standard deviation. PD = Parkinson’s disease.
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target locations (leftwards and rightwards) and the trial type
(Go and No-Go) were randomized within and across partici-
pants. A short series of 40 presentations of the targets were
used at the beginning of the session for calibration.
Data preprocessing
Eye movement data were downloaded from the saccadometer
to a laptop and preprocessed using an automated validation
program in Latency Meter 2.3 (Ober consulting). The valid-
ation program removed erroneous trials due to blinks, as well
as grossly abnormal proﬁles as determined by the instantan-
eous velocity, acceleration, and position of eye movement
traces, and rejection criteria for either the peak velocity or
saccadic duration (Ober et al., 2003).
For trials with valid saccades, the saccadic latency was
deﬁned as the time interval between the target onset and the
onset of the saccade. The saccadic latency data were pooled
for leftward and rightward targets to increase statistical
power, because the saccadic latencies did not signiﬁcantly
differ between the two target locations [t(68) = 0.63,
P = 0.53, paired t-test]. Four behavioural measures were ob-
tained for each participant: (i) the rate of omission errors in
Go trials; (ii) the rate of commission errors in No-Go trials;
(iii) mean saccadic latency in successful Go trials; and (iv)
mean saccadic latency in No-Go trials with commission errors.
Hierarchical drift-diffusion model for
the Go/No-Go task
The saccadic Go/No-Go task can be conceptualized as a rapid
two-alternative forced choice between a Go decision and a No-
Go decision (Gomez et al., 2007). The decision process has
been described by a widely accepted DDM (Ratcliff and
McKoon, 2008). The model can be described by four param-
eters (Fig. 1B): boundary separation a indicating the distance
between the two decision boundaries, drift rate v indicating the
rate of evidence accumulation, a priori decision bias z indicat-
ing the starting point of the accumulator at stimulus onset, and
non-decision time Ter indicating the time used for non-decision
processes (e.g. stimulus encoding or response execution
latencies).
Most decision-making tasks require selecting between two
overt responses. For example, in a lexical decision task, par-
ticipants are instructed to make ‘word’ or ‘non-word’ decisions
by pressing one of two response buttons (Ratcliff et al., 2004).
In this case, the two decision boundaries in the DDM corres-
pond to the two choice alternatives, and the model predicts the
decision time for each choice as the latency of accumulator
activity reaching the corresponding boundary. However, the
Go/No-Go task differs from the classical binary decision
tasks in that response time for a No-Go decision cannot be
explicitly measured. In line with previous studies (Gomez
et al., 2007), we assumed an implicit lower decision boundary
for No-Go decisions and an upper boundary for Go decisions
(Fig. 1B), and ﬁtted the DDM to individual participant’s re-
sponses (i.e. the proportion of Go and No-Go choices) as well
as the distributions of saccadic latencies (i.e. in Go trials with
successful responses or in No-Go trials with commission
errors).
The hierarchical DDM toolbox was used to ﬁt the data
(Wiecki et al., 2013). The hierarchical model assumes that
participants are random samples drawn from group-level dis-
tributions, and uses Bayesian statistical methods to simultan-
eously estimate parameter distributions at both the group level
and the individual-participant level (Vandekerckhove et al.,
2011). The Bayesian approach has been shown to be more
robust in recording model parameters than other methods
such as maximum likelihood estimation when limited data
are available (Jahfari et al., 2013). This important feature
greatly beneﬁts the current study, because of substantial con-
straints on the duration of the task for patients.
We examined four variants of the DDM with different par-
ameter constraints. The ﬁrst model assumed an unbiased start-
ing point (z = 0.5) and the same absolute value for the drift
rate in the Go and No-Go conditions (i.e. if the drift rate in the
Go condition is v, then the drift rate in the No-Go condition is
v). The second model assumed an unbiased starting point but
allowed the drift rate to vary between the two conditions. The
third model assumed variable starting points across partici-
pants and the same absolute value for the drift rate in the
two conditions. The fourth model assumed variable starting
points and different drift rates in the two conditions. Each
model parameter had three group-level distributions corres-
ponding to the three participant groups (PSP, Parkinson’s dis-
ease and controls) and individual-level distributions for each
participant.
For each model, we generated 15 000 samples from the joint
posterior distribution of all model parameters by using
Markov chain Monte Carlo methods (Gamerman and Lopes,
2006). The initial 5000 samples were discarded as burn-in to
minimize the effect of initial values on the posterior inference
(see Wiecki et al., 2013 for more details of the procedure).
Geweke statistic was used to assess the convergence of the
Markov chains (Gelman et al., 2004). Parameter estimates in
all models were converged after 15 000 samples.
Statistical analysis
ANOVAs and post hoc t-tests were used for statistical analysis
of the behavioural measures between groups. Statistical infer-
ence on model parameters was made by two complementary
approaches. First, for each parameter at the individual-partici-
pant level, the mean of its posterior distribution was used as a
point estimate for comparing between groups. Second, for each
parameter at the group level, Bayesian inference was used to
directly compare its posterior distribution between groups
(Lindley, 1965; Berger and Bayarri, 2004; Gelman et al.,
2004; Kruschke, 2010). We use P to refer to classical frequen-
tist P-values, and Pp|D to refer to the proportion of posteriors
supporting the testing hypothesis at the group level from
Bayesian inference.
Model-based classification
of individual patients
To investigate how well the model parameters can distinguish
between the three participant groups, we used a three-way
linear logistic regression classiﬁer implemented in Weka
(http://www.cs.waikato.ac.nz/ml/weka). For each participant,
the feature space for classiﬁcation included mean estimates of
4 | BRAIN 2015: Page 4 of 13 J. Zhang et al.
 by guest on N
ovem
ber 19, 2015
http://brain.oxfordjournals.org/
D
ow
nloaded from
 
the ﬁve model parameters from the best ﬁtted model (a, z, Ter,
vgo, and vno-go). A leave-one-out cross-validation procedure
was performed to optimize the use of this limited dataset. In
each cross-validation fold, one participant was ﬁrst removed
and the remaining participants’ data were used as a training
set to build the classiﬁer. The participant left out was then
classiﬁed into one of the three groups (PSP, Parkinson’s disease
and controls), independently from the training set.
Classiﬁcation performance was evaluated by the hit rate, pre-
cision, and the area under the receiver operating characteristic
(ROC) curve (AUC) of each class, averaged across all cross-
validations.
To assess whether the model parameters provide better dis-
crimination than simple behavioural measures, we performed
the same classiﬁcation procedure with a second feature space,
which contained four raw behavioural measures (omission
rate, commission rate, mean saccadic latencies in the Go and
No-Go conditions).
We used permutation tests to evaluate whether DDM par-
ameters are better than raw behavioural measures in the clas-
siﬁcation of a participant’s group. Three evaluation criteria
were used: weighted average of hit rate across the three classes,
weighted average of precision, and weighted average of AUC.
The signiﬁcance of each criterion was determined by compar-
ing the observed evaluation criterion with its distribution
under the null hypothesis, which was generated by 100 000
random permutations of leave-one-out classiﬁcation results be-
tween the two feature sets. The permutation P-value was then
obtained by calculating the probability of the permuted sam-
ples exceeding the observed value in the data.
Results
Behavioural results
Details of participant demographics, disease severity and
neuropsychological scores are given in Table 1. The three
groups were well matched for age [F(2,68) = 0.42, P = 0.66]
and gender (P = 0.51, chi-square test). As expected, cogni-
tive performance differed signiﬁcantly between groups
[MMSE: F(2,68) = 8.41, P5 0.001; ACE-R: F(2,68) =
16.34, P5 0.00001]. Both patient groups had lower
MMSE scores than controls [PSP: t(43) = 3.79,
P50.001; Parkinson’s disease: t(48) = 2.76, P5 0.01]
and total ACE-R scores [PSP: t(43) = 5.74, P50.00001;
Parkinson’s disease: t(48) = 2.63, P5 0.05]. Patients with
PSP also had lower ACE-R [t(41) = 3.04, P50.01] and
marginally lower MMSE [t(41) = 1.95, P = 0.06] than pa-
tients with Parkinson’s disease.
Behavioural results are shown in Fig. 2. There were sig-
niﬁcant group differences in the omission error in the Go
condition [F(2,68) = 12.37, P5 0.0001; partial 2 = 0.27],
and in the commission error in the No-Go condition
[F(2,68) = 7.20, P5 0.001; partial 2 = 0.18]. Compared
with controls, both patient groups had higher omission
errors [PSP: t(43) = 4.45, P5 0.0001; Parkinson’s
disease: t(48) = 3.58, P5 0.001] and higher commission
errors [PSP: t(43) = 3.42, P50.001; Parkinson’s
disease: t(48) = 3.27, P5 0.01]. Patients with PSP had
higher omission errors than patients with Parkinson’s dis-
ease [t(41) = 2.49, P50.05], and the two patient groups
had similar commission errors [t(41) = 0.83, P = 0.41].
There was no signiﬁcant group difference in the saccadic
latency in successful Go trials [F(2,68) = 2.34, P = 0.10;
partial 2 = 0.07] or No-Go trials with commission errors
[F(2,68) = 1.65, P = 0.20; partial 2 = 0.05].
Hierarchical drift-diffusion model fit
to saccadic Go/No-Go data
We compared four variants of the hierarchical DDM for
the saccadic Go/No-Go task, varying systematically in con-
straints on whether the starting point was biased towards
one of the two decision boundaries, and whether the drift
rate varied between Go and No-Go conditions, because the
drift rate is often assumed to change between stimulus con-
ditions (Gomez et al., 2007). For each model, a Bayesian
parameter estimation procedure was used to estimate the
joint posterior distributions of all the model parameters,
given the observed behavioural data. To identify the
model with the best ﬁt, we estimated the deviance informa-
tion criterion (DIC) value of each model, a goodness-of-ﬁt
measure for Bayesian models with a penalty for additional
free model parameters (Spiegelhalter et al., 2002).
The best model (with the lowest DIC value) to describe
the data across Go/No-Go conditions and participants had
a variable starting point between participants and variable
drift rates between Go and No-Go conditions (Model 4 in
Fig. 3A, see also Fig. 3B). To evaluate the model ﬁt, we
compared posterior model predictions with the observed
data. The posterior predictions of the best model were
generated by averaging 500 simulations of the same
amount of model predicted data as observed in the experi-
ment using posterior parameter estimates. There was a
good agreement between the observed data and the
model predictions across conditions in all three participant
groups (Fig. 3C).
Inferences from model parameters
Figure 4 shows the posterior parameter estimates for the
three participant groups. We used both frequentist and
Bayesian statistics to examine group differences in model
parameters.
Response bias
The starting point was signiﬁcantly larger than 0.5 in all
three groups [PSP: t(18) = 13.10, P5 1  109, PP|D 1;
Parkinson’s disease: t(23) = 7.85, P5 1  107, PP|D 1;
control: t(25) = 9.52, P5 1  109, PP|D1], indicating
that there is a prepotent bias towards the Go response
(i.e. the upper decision boundary). However, the absolute
magnitude was small in healthy controls and we observed a
signiﬁcant difference in the response bias between groups
[F(2,68) = 18.16, P5 0.000001, partial 2 = 0.36]. No
Decision deficits in saccadic inhibition BRAIN 2015: Page 5 of 13 | 5
 by guest on N
ovem
ber 19, 2015
http://brain.oxfordjournals.org/
D
ow
nloaded from
 
signiﬁcant difference was observed between patients with
Parkinson’s disease and controls [t(48) = 1.28, P = 0.21,
PP|D = 0.86]. The PSP group had a signiﬁcantly larger bias
towards the Go response than the Parkinson’s group
[t(41) = 4.20, P5 0.001, PP|D1] and controls
[t(43) = 6.14, P5 0.000001, PP|D1], indicating that des-
pite their difﬁculty in moving because of akinetic rigidity,
patients with PSP are actually close to the movement
threshold.
Accumulation of evidence for the response
There was a signiﬁcant group difference in the drift rate in
both Go and No-Go conditions [Go: F(2,68) = 36.68,
P51  1010, partial 2 = 0.53; No-Go: F(2,68) = 4.38,
P50.05, partial 2 = 0.12]. The drift rate in the Go con-
dition was lower in the PSP group than that in the
Parkinson’s disease group [t(41) = 2.96, P5 0.01,
PP|D = 0.99] and controls [t(43) = 6.54, P51  107,
PP|D1], whereas the patients with Parkinson’s disease
also had a lower Go drift rate than the controls
[t(48) = 6.54, P5 1  107, PP|D 1]. For the No-Go
condition, both patient groups had lower drift rate than
controls [PSP: t(43) = 2.33, P5 0.05, PP|D = 0.98;
Parkinson’s disease: t(48) = 3.02, P5 0.01, PP|D = 0.99],
but no signiﬁcant difference was observed between the
two patient groups [t(41) = 0.25, P = 0.80, PP|D = 0.61].
Non-decision time and boundary separation
The three participant groups signiﬁcantly differed in their
non-decision time [F(2,68) = 15.63, P50.00001, partial
2 = 0.32]. Both patient groups had a shorter non-decision
time than controls [PSP: t(43) = 4.54, P5 0.0001,
PP|D 1; Parkinson’s disease: t(48) = 4.30, P5 0.0001,
PP|D 1], and the non-decision time was similar between
the two patient groups [t(41) = 0.89, P = 0.38, PP|D = 0.74].
The three participant groups had similar boundary separ-
ation between thresholds for Go and No-Go decisions
[F(2,68) = 0.14, P = 0.87, partial 2 = 0.004].
Model-based classification
We used a leave-one-out cross validation procedure in a
three-way classiﬁcation of participant groups (PSP,
Parkinson’s disease, and controls). First we used the four
raw behavioural measures (commission error, omission
error, saccadic latency distributions in the Go and No-Go
conditions) as the feature space. As expected from the de-
scriptive statistics and group contrasts, there was only a
modest ability to classify participants, such that 50–60%
of patients were correctly classiﬁed (Table 2). The asso-
ciated ROC curves illustrate the limited performance of
behavioural measures, and in particular, show limited dis-
crimination of the two patient groups (Fig. 5).
We then used the model parameters as a second feature
space for classiﬁcation using the same cross-validation pro-
cedure. The model-based approach showed superior sensi-
tivity and precision in classiﬁcation across the three groups
(475%) (Table 2). The accompanying ROC curves illus-
trate the signiﬁcant enhanced ability of model parameters
to differentiate participants (Fig. 5). The signiﬁcant im-
provement in classiﬁcation using model parameters over
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Figure 2 Behavioural results. The mean proportion of errors (top) and saccadic latencies (bottom) in the Go/No-Go task. The error bars
represent the standard errors across participants in each group. In all panels, asterisks denote statistical significance at *P5 0.05, **P5 0.01, or
***P5 0.001 from independent sample t-tests and n.s. denotes non-significant difference. PD = Parkinson’s disease.
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raw behavioural data was conﬁrmed with permutation
tests.
Discussion
We conﬁrmed the impairment of response inhibition in pa-
tients with PSP and Parkinson’s disease, but identiﬁed sig-
niﬁcant differences in these disorders on the decision
processes that lead to disinhibition. Both patient groups
made more commission errors despite akinesia (O’Sullivan
et al., 2010; Nombela et al., 2014). However, the striking
result in PSP was that patients were strongly biased to-
wards making a response and yet were severely impaired
at accumulating the necessary evidence to commit to that
response (Fig. 4E). This combination provides a
parsimonious explanation for the apparently paradoxical
combination of impulsivity and akinesia seen in this
disease.
The study highlights the beneﬁts of formal computational
modelling of behaviour for a better understanding of dis-
ease mechanisms. Bayesian parameter estimation of the
drift-diffusion model provided a highly efﬁcient and
robust measure of an individual’s performance, with
many fewer data needed in comparison with other
approaches in preclinical and normative studies
(Vandekerckhove et al., 2011; Wiecki et al., 2013;
Zhang and Rowe, 2014). This approach enables one to
infer disease-speciﬁc changes at the group level.
The model decomposed behavioural data into ﬁve par-
ameters associated with Go/No-Go decisions: response bias,
drift rates in Go and No-Go conditions, boundary
A
C
B
Figure 3 Model comparison and model fits. (A) The deviance information criterion (DIC) value differences between the best fit model
(Model 4) and the other three model variants, for each group separately (dash lines) and all participants combined (solid lines). (B) The graphical
representation of the best fit model. The shaded node Data(g,p,i,j) indicates the observed data of each group (g), participant (p), condition (i) and
trial (j). Nodes a, Ter, z, and v are parameters of the drift-diffusion model, each with a group distribution for each patient group with mean m and
standard deviation . (C) Posterior predictive data distributions from the best fit model. The distribution along the positive x-axis shows the
latency distribution in the Go condition (correct Go trials), and the distribution along the negative x-axis shows the latency distribution in the No-
Go condition (commission error trials). Each panel shows the normalized histograms of the observed data and the model prediction (black lines).
The area under the curve on the positive x-axis corresponds to the observed and predicted accuracy in the Go condition. The area under the
curve along the negative x-axis corresponds to the commission error in the No-Go condition. PD = Parkinson’s disease.
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separation and non-decision time. These model parameters
also improved the discrimination of patients and controls
over the common behavioural measures (errors and reaction
times), with higher precision and superior signal detection in
classiﬁcation (as receiver operating characteristics). Simple
behavioural measures, like the mean latency of response,
have been examined before in both diseases, but with mixed
conclusions. In patients with Parkinson’s disease, pro-
saccades may have longer latency to controls (Michell et al.,
2006) or normal (Chan et al., 2005; van Koningsbruggen
et al., 2009), and reﬂective saccades may be faster (Briand
et al., 2001). Horizontal saccadic latency in PSP has been
reported to be either slower than controls (Linder et al.,
2012; Ghosh et al., 2013) or normal, at least at the group
level (Pierrot-Deseilligny et al., 1989; Vidailhet et al., 1994).
By using the full distribution of response latencies and accur-
acy, the model-based approach instead provides clear evi-
dence of abnormality in both PSP and Parkinson’s disease.
This result implies that data analysis methods for disease
monitoring or drug response monitoring need to be more
sophisticated than basic behavioural measures. The effect of
a candidate drug on behaviour may be missed if crude metrics
like reaction time alone are used. Ourmodelling approach has
greater potential to support clinical trials.
The model-based analysis revealed that behavioural im-
pairments of response inhibition in PSP and Parkinson’s
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Figure 4 Posterior estimates of the hierarchical drift-diffusion model parameters for each group. (A) Response bias z. (B) Non-
decision time Ter. (C) Draft rates v for Go (solid lines) and No-Go (dashed lines) conditions. (D) Boundary separation a. In all panels, the asterisks
denote significant difference between PSP and patients Parkinson’s disease from frequentist and Bayesian statistics, and n.s. denotes non-significant
difference. (E) The schematic diagram of the altered Go/No-go decision processes in patients. PSP leads to an exaggerated response bias towards
Go decisions (i.e. the upper boundary), and a reduced non-decision time, but that the further accumulation of evidence towards a response is
accumulated very slowly, predisposing patients to inhibition errors but without prolonged latencies of actual responses. In contrast, Parkinson’s
disease leads to a shorter non-decision time but normal initial response bias and a mild reduction in the rate of accumulation of evidence.
PD = Parkinson’s disease.
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disease arise for different reasons. This implies that effective
treatment strategies for one disease may not work for the
other. However, in both patient groups and controls, a
response bias towards Go decisions was consistently
observed. This could be explained by the reactive nature
of Go saccades and an underlying bias in response neuron
populations. For example, neurons in the intermediate layer
of the superior colliculus have stronger sustained activities
in Go trials than No-Go trials (Pare´ and Wurtz, 2001),
which might enhance descending supranuclear control for
saccades.
Patients with PSP demonstrated more severe response
bias than patients with Parkinson’s disease and control sub-
jects, which could be explained by several pathophysio-
logical mechanisms. Abnormal ocular ﬁxation, such as
square wave jerks, is more apparent in PSP (Garbutt
et al., 2004; Otero-Millan et al., 2011) than in
Parkinson’s disease (Rascol et al., 1991). This has been
attributed to midbrain atrophy in PSP (Kato et al., 2003).
The disease interrupts inputs to omnipause neurons (e.g.
from rostral superior colliculus, see Everling et al., 1998),
which in turn changes the reciprocal discharge patterns of
omnipause neurons and burst neurons in the pontine
reticular formation. At the behavioural level, the affected
brainstem circuitry would be prone to initiate saccades,
leading to a strong bias towards Go responses in the Go/
No-Go task.
It is also worth considering the contribution of cortical
pathology. 18F-ﬂuorodeoxyglucose PET imaging has identi-
ﬁed decreased metabolic activity in the medial prefrontal
cortex, anterior cingulate, and ventrolateral prefrontal
cortex in PSP (Eckert et al., 2008). These regions are part
of the cortical network essential for executive control
(Ridderinkhof et al., 2004) and response inhibition of
both eye and hand movements (Leung and Cai, 2007).
Therefore severe response bias in PSP may also result
from cortical degeneration, which imbalances the binary
decision between Go and No-Go choices (Mulder et al.,
2012).
Patients’ with PSP and Parkinson’s disease had slower
drift rates than controls in both Go and No-Go conditions.
This result suggests the effects of the diseases on the accu-
mulation of decision signal: prolonging the latency to reach
a decision boundary and thereby increasing response
errors. Previous work on Parkinson’s disease is consistent
with this account. Briand et al. (1999) showed longer
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Figure 5 Receiver operating characteristic curves of each class in the leave-one-out three-way classification based on the
model parameters (solid lines) and raw behavioural measures (dash lines). PD = Parkinson’s disease.
Table 2 Leave-one-out cross-validation results from three-way linear logistic regression classifiers
Feature sets True positive rate Precision AUC of ROC curves
PSP
group
PD
group
Control
group
Weighted
average
PSP
group
PD
group
Control
group
Weighted
average
PSP
group
PD
group
Control
group
Weighted
average
DDM parameters 0.73 0.67 0.85 0.75 0.82 0.73 0.73 0.76 0.92 0.81 0.93 0.89
Behavioural measures 0.63 0.50 0.77 0.64 0.75 0.55 0.65 0.64 0.82 0.66 0.85 0.78
Permutation P-values
for DDM superiority
P5 0.05 P = 0.07 P5 0.0001
Permutation tests were used to compare the classification results based on DDM parameters and raw behavioural measures. For classification based on DDM parameters, three PSP
patients were misclassified as controls and two as Parkinson’s disease (PD) patients; while five patients with Parkinson’s disease were misclassified as controls and three as patients
with PSP. For classification based on behavioural measures, two patients with PSP were misclassified as controls and five as patients with Parkinson’s disease; whereas nine patients
with Parkinson’s disease were misclassified as controls and three as patients with PSP.
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saccadic latency in patients with Parkinson’s disease in an
anti-saccade task (Antoniades et al., 2013). Similar results
were reported in studies using pro-saccade paradigms
(Amador et al., 2006; Michell et al., 2006) and manual
reaction time tasks (Gauntlett-Gilbert and Brown, 1998).
Using voxel-based morphometry, Perneczky et al. (2011)
identiﬁed that the longer and more variable saccadic la-
tency in patients with Parkinson’s disease was associated
with lower grey matter volume of the frontal eye ﬁeld
and lateral prefrontal cortex. The frontal-subcortical path-
way plays a central role for the generation of saccades with
precise timing (Robinson and Fuchs, 2001), and the accur-
ate saccade control in response to different task demands
via the prefrontotectal tract (Robinson and Fuchs, 2001).
In Parkinson’s disease, cortical and subcortical atrophy dis-
rupts this saccadic decision network (Tinaz et al., 2011;
Rae et al., 2012), which may give rise to the lowered
drift rates observed in the current study. Similarly, pro-
longed pro-saccade latencies have also been reported in
PSP (Ghosh et al., 2010). We speculate that this is also
caused by atrophy in saccadic control regions (Ghosh
et al., 2012), which is yet to be conﬁrmed in imaging stu-
dies that correlate with saccade latency.
An intriguing ﬁnding is that patients with PSP and those
with Parkinson’s disease had shorter non-decision time
than controls. The non-decision time reﬂects the latency
of early sensory encoding external to the oculomotor deci-
sion process (Ratcliff and McKoon, 2008; Wagenmakers,
2009). Therefore, shorter non-decision time could imply
enhanced early sensory processing in patients. This result
may at ﬁrst seem surprising, given motor akinesia and cog-
nitive slowing associated with the diseases. Nevertheless,
our result is consistent with EEG evidence. In a visual odd-
ball paradigm, the latency of the early event-related poten-
tial N1 in patients with Parkinson’s disease was shorter
than that in healthy control subjects (Wang et al., 2001;
Li et al., 2003), suggesting excessive attention or enhanced
sensory processing in patients. This concurs with the hy-
pothesis (Palop et al., 2006) that impaired cognitive func-
tion in neurodegenerative disorders can be compensated for
by additional processing, such as increased reliance on
visual features (Bloem et al., 2004; Helmich et al., 2007).
In both PSP and Parkinson’s disease there is abundant
evidence for impulsive limb movements and global behav-
iours (Litvan et al., 1996a; Aarsland et al., 2001; Robert
et al., 2009; O’Sullivan et al., 2010; Jahanshahi et al.,
2014; Nombela et al., 2014). For example, patients with
Parkinson’s disease have higher commission errors than
controls in manual Go/No-Go tasks (Nombela et al.,
2014), and longer stop-signal reaction time in manual
stop-signal tasks (Gauggel et al., 2004; Ye et al., 2014a).
Therefore the failure of response inhibition is not restricted
to eye movements as studied here. It is possible that the
origin of limb inhibition deﬁcits is different to oculomotor
inhibition deﬁcits, but we propose that the two types of
decision deﬁcit are homologous. Several lines of research
support this hypothesis. For instance, limb kinetics affect
saccadic outputs in health (Snyder et al., 2002; van
Donkelaar et al., 2004), and both are comparably impaired
in Parkinson’s disease (Gibson et al., 1987). Onset latencies
for eye and hand movements are correlated in many tasks
(Lunenburger et al., 2000; Sailer et al., 2000; Gribble et al.,
2002; Snyder et al., 2002), including in stop-signal tasks
(Boucher et al., 2007). Furthermore, the same accumulator
model, assuming competitions between a Go process and a
Stop process during response inhibition, provides a good ﬁt
for data from both saccadic and manual stop-signal tasks
(De Jong et al., 1990; Hanes et al., 1998; Gopal and
Murthy, 2015). Therefore, although the inhibited move-
ments of saccades and manual movements are not con-
trolled by an identical anatomical pathway, different
inhibitory systems may share the same computational prin-
cipals: disruption to this process therefore gives rise to simi-
lar impulsivity across response modalities in diseases. This
account is consistent with the ﬁndings that deep brain
stimulation in Parkinson’s disease inﬂuences inhibitory con-
trols over saccadic as well as manual responses (van den
Wildenberg et al., 2006; Yugeta et al., 2010; Swann et al.,
2011; Jahanshahi, 2013).
There are several limitations to this study. First, the
severe response bias towards Go decisions indicates that
PSP is associated with impulsivity in saccadic inhibition.
However, impulsivity is a multi-modal construct (Dalley
et al., 2011) and our study alone does not show whether
performance impairments in behavioural paradigms such as
the Go/No-Go task are associated with different domains
of cognition and impulsivity. Saccadic latencies target im-
paired decision processes in the cortical and subcortical
supranuclear network and cognitive precursors to oculo-
motor inhibition. This is not necessarily a sensitive measure
of a broad range of other higher-order cognitive deﬁcits in
Parkinson’s disease and PSP (Burrell et al., 2014; Yarnall
et al., 2014). Nevertheless, saccadic control involves wide-
spread cortico-striato-thalamo-cortical circuits that are es-
sential to cognition (Alexander et al., 1990; Hikosaka
et al., 2000), which makes saccades a valuable tool for
understanding cognitive dysfunctions (Leigh and Kennard,
2004). A recent study on the fractionation of impulsivity
provides promising results in this regard. Commission
errors in the saccadic Go/No-Go task, together with other
tasks with demands on conﬂict resolution, are associated
with the self-assessment of impulsive behaviours on the
Barrett Impulsivity Scale (Nombela et al., 2014), suggesting
the sensitivity and broad relevance of saccadic tasks in re-
lation to clinical features.
Second, we have reported that model parameters were
more informative than the commonly derived behavioural
measures (mean latencies and errors) in classiﬁcation. This
does not mean that the model parameters are more inform-
ative than the raw data, but reﬂects the fact that the model
parameters are sensitive to higher order moments of the
reaction time distributions, especially the skew, kurtosis
and variance. Addition of these higher order moments
might improve accuracy of classiﬁcation, but would not
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provide the mechanistic interpretation of the deﬁcits as re-
vealed from the DDM.
Finally, the patients were recruited from a regional clinic
and therefore may not fully represent the whole population
of patients at different disease stages. We included a modest
number of patients in each group, which was sufﬁcient for
detecting disease-speciﬁc differences. Given the fact that
saccadometry is well tolerated in patients, our protocol
could be extended to a larger cohort, from which the
increased statistical power would allow one to further in-
vestigate the association between model parameters and
clinical measures. Interestingly, a recent longitudinal study
showed that, in PSP, oculomotor function and cognition
were affected early in the course of the illness (Ghosh
et al., 2013). Therefore, although our approach is poten-
tially useful to explore the effects of treatment or disease on
oculomotor and decision-making systems, model-based
analysis of longitudinal data would be required to identify
appropriate biomarkers for tracking disease progression in
individual patients.
In conclusion, impairments of saccadic response inhib-
ition occur in both PSP and Parkinson’s disease. Both dis-
eases impaired information sampling during decision-
making, while patients with PSP showed an additional
stronger, disease-speciﬁc bias towards Go decisions. We
further demonstrated that computational modelling is
more efﬁcient than raw behavioural measures when
used for discriminating between patients. These results
have the potential to be exploited in future diagnostic and
therapeutic studies for the comprehensive understanding
of different disease mechanisms and in the evaluation of
disease-modifying treatments.
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